AbbVie Inc. (ABBV)

AbbVie Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	6,569	5,229	5,524	12,814	9,201	9,746
Short-Term Investments	-	28	31	2	28	84
Cash & Short-Term Investments	6,569	5,257	5,555	12,816	9,229	9,830
Cash Growth	1.58%	-5.37%	-56.66%	38.87%	-6.11%	15.93%
Accounts Receivable	13,824	12,589	10,919	11,155	11,254	9,977
Inventory	5,127	4,951	4,181	4,099	3,579	3,128
Other Current Assets	8,149	6,265	4,927	4,932	4,401	4,993
Total Current Assets	33,669	29,062	25,582	33,002	28,463	27,928
Net Property, Plant & Equipment	5,796	5,628	5,134	4,989	4,935	5,110
Other Intangible Assets	49,139	52,641	60,068	55,610	67,439	75,951
Goodwill	35,519	35,640	34,956	32,293	32,156	32,379
Long-Term Investments	266	268	279	304	241	277
Other Long-Term Assets	10,726	10,721	9,142	8,513	5,571	4,884
Total Assets	135,115	133,960	135,161	134,711	138,805	146,529

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	33,301	34,734	31,945	30,650	25,402	22,699
Short-Term Debt	-	2,499	-	-	1	14
Current Portion of Long-Term Debt	8,341	6,056	6,804	7,191	4,135	12,481
Total Current Liabilities	41,642	43,289	38,749	37,841	29,538	35,194
Long-Term Debt	62,481	58,941	60,340	52,194	59,135	64,189
Other Long-Term Liabilities	36,880	34,958	32,708	34,279	32,845	31,710
Total Long-Term Liabilities	99,361	93,899	93,048	86,473	91,980	95,899
Total Liabilities	141,003	137,188	131,797	124,314	121,518	131,093

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	18	18	18	18	18	18
Treasury Stock	-10,618	-9,146	-8,201	-6,533	-4,594	-3,143
Additional Paid-in Capital	23,156	22,495	21,333	20,180	19,245	18,305
Accumulated Other Comprehensive Income	-1,158	-1,144	-1,925	-2,305	-2,199	-2,899
Retained Earnings	-17,333	-15,493	-7,900	-1,000	4,784	3,127
Total Common Shareholders' Equity	-5,935	-3,270	3,325	10,360	17,254	15,408
Minority Interest	47	42	39	37	33	28
Shareholders' Equity	-5,888	-3,228	3,364	10,397	17,287	15,436
Total Liabilities & Equity	135,115	133,960	135,161	134,711	138,805	146,529

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	70,822	67,496	67,144	59,385	63,271	76,684
Net Cash (Debt)	-64,253	-62,239	-61,589	-46,569	-54,042	-66,854
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-36.24	-35.10	-34.74	-26.27	-30.39	-37.62
Book Value	-5,935	-3,270	3,325	10,360	17,254	15,408
Book Value Per Share	-3.35	-1.84	1.88	5.84	9.70	8.67
Tangible Book Value	-90,593	-91,551	-91,699	-77,543	-82,341	-92,922
Tangible Book Value Per Share	-51.10	-51.64	-51.72	-43.74	-46.31	-52.29

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Aug 3, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 12, 2026

Data Sources Report a data error